The Current Ratio as of September 2024 (TTM) for Provention Bio, Inc. (PRVB) is 1.93

According to Provention Bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.93. This represents a change of -53.15% compared to the average of 4.12 of the last 4 quarters.

Provention Bio, Inc. (PRVB) Historical Current Ratio (quarterly & annually)

How has PRVB Current Ratio performed in the past?

The mean historical Current Ratio of Provention Bio, Inc. over the last ten years is 12.45. The current 1.93 Current Ratio has changed 1.45% with respect to the historical average. Over the past ten years (40 quarters), PRVB's Current Ratio was at its highest in in the September 2018 quarter at 53.75. The Current Ratio was at its lowest in in the December 2016 quarter at 0.

Provention Bio, Inc. (PRVB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Provention Bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Provention Bio, Inc. (PRVB) Average Current Ratio

How has PRVB Current Ratio performed in the past?

The current Current Ratio of Provention Bio, Inc. (PRVB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Provention Bio, Inc. (PRVB) Current Ratio vs. Peers

How is PRVB’s Current Ratio compared to its peers?

Provention Bio, Inc.’s Current Ratio is less than IVERIC bio, Inc. (15.53), less than Immunovant, Inc. (13.08), less than Akero Therapeutics, Inc. (24.89), less than Madrigal Pharmaceuticals, Inc. (8.72), less than Apellis Pharmaceuticals, Inc. (5.08), less than Prometheus Biosciences, Inc. (0), less than Viking Therapeutics, Inc. (37.56), less than Intercept Pharmaceuticals, Inc. (37.69), less than Terns Pharmaceuticals, Inc. (4.22), less than Reata Pharmaceuticals, Inc. (21.02), less than BioLineRx Ltd. (3.21), greater than Ardelyx, Inc. (1.61), less than Lexicon Pharmaceuticals, Inc. (4.21), less than Seres Therapeutics, Inc. (11.51), greater than ImmunityBio, Inc. (1.38), less than null (3.91),

Build a custom stock screener for Provention Bio, Inc. (PRVB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Provention Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Provention Bio, Inc. (PRVB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Provention Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.